Skip to main content
Top
Published in: Annals of Behavioral Medicine 2/2009

01-04-2009 | Original Article

Costing Behavioral Interventions: A Practical Guide to Enhance Translation

Authors: Debra P. Ritzwoller, Ph.D., Anna Sukhanova, M.A., Bridget Gaglio, M.P.H., Russell E. Glasgow, Ph.D.

Published in: Annals of Behavioral Medicine | Issue 2/2009

Login to get access

Abstract

Background/Purpose

Cost and cost effectiveness of behavioral interventions are critical parts of dissemination and implementation into non-academic settings. Due to the lack of indicative data and policy makers’ increasing demands for both program effectiveness and efficiency, cost analyses can serve as valuable tools in the evaluation process.

Methods

To stimulate and promote broader use of practical techniques that can be used to efficiently estimate the implementation costs of behavioral interventions, we propose a set of analytic steps that can be employed across a broad range of interventions.

Results/Conclusions

Intervention costs must be distinguished from research, development, and recruitment costs. The inclusion of sensitivity analyses is recommended to understand the implications of implementation of the intervention into different settings using different intervention resources. To illustrate these procedures, we use data from a smoking reduction practical clinical trial to describe the techniques and methods used to estimate and evaluate the costs associated with the intervention. Estimated intervention costs per participant were $419, with a range of $276 to $703, depending on the number of participants.
Literature
1.
go back to reference Glasgow RE, Emmons KM. How can we increase translation of research into practice? Annu Rev Pub Health. 2007; 281: 413–433.CrossRef Glasgow RE, Emmons KM. How can we increase translation of research into practice? Annu Rev Pub Health. 2007; 281: 413–433.CrossRef
2.
go back to reference Grosse SD, Teutsch SM, Haddix C. Lessons from cost-effectiveness research for United States public health policy. Annu Rev Pub Health. 2007; 28: 365–391.CrossRef Grosse SD, Teutsch SM, Haddix C. Lessons from cost-effectiveness research for United States public health policy. Annu Rev Pub Health. 2007; 28: 365–391.CrossRef
3.
go back to reference Hoffmann C, Stoykova BA, Nixon J, et al. Do healthcare decision makers find economic evaluations useful? The findings of focus group research in UK health authorities. Value Health. 2002; 52: 71–78.PubMedCrossRef Hoffmann C, Stoykova BA, Nixon J, et al. Do healthcare decision makers find economic evaluations useful? The findings of focus group research in UK health authorities. Value Health. 2002; 52: 71–78.PubMedCrossRef
5.
go back to reference Sloan FA, Whetten-Goldstein K, Wilson A. Hospital pharmacy decision, cost containment, and the use of cost-effectiveness analysis. Soc Sci Med. 1997; 454: 523–533.PubMedCrossRef Sloan FA, Whetten-Goldstein K, Wilson A. Hospital pharmacy decision, cost containment, and the use of cost-effectiveness analysis. Soc Sci Med. 1997; 454: 523–533.PubMedCrossRef
6.
go back to reference Rogers EM. Diffusion of innovations. 5th ed. New York: Free Press; 2003. Rogers EM. Diffusion of innovations. 5th ed. New York: Free Press; 2003.
7.
go back to reference Glasgow RE, Linnan L. Evaluation of theory-based Interventions. In: Glanz K, ed. Health Education: Theory, research and Practice. 4th ed. Hoboken, NJ: Jossey-Bass; 2007. Glasgow RE, Linnan L. Evaluation of theory-based Interventions. In: Glanz K, ed. Health Education: Theory, research and Practice. 4th ed. Hoboken, NJ: Jossey-Bass; 2007.
8.
go back to reference Ronckers ST, Groot W, Ament AJ. Systematic review of economic evaluations of smoking cessation: Standardizing the cost-effectiveness. Med Decis Making. 2005; 254: 437–438.PubMedCrossRef Ronckers ST, Groot W, Ament AJ. Systematic review of economic evaluations of smoking cessation: Standardizing the cost-effectiveness. Med Decis Making. 2005; 254: 437–438.PubMedCrossRef
9.
go back to reference Cromwell J, Bartosch WJ, Fiore MC, et al. Cost-effectiveness of the clinical practice recommendations in the AHCPR Guideline for Smoking Cessation. JAMA. 1997; 27821: 1759–1766.PubMedCrossRef Cromwell J, Bartosch WJ, Fiore MC, et al. Cost-effectiveness of the clinical practice recommendations in the AHCPR Guideline for Smoking Cessation. JAMA. 1997; 27821: 1759–1766.PubMedCrossRef
10.
go back to reference Coffield AB, Maciosek Mv, McGinnis JM, et al. Priorities among recommended clinical preventive services. Am J Prev Med. 2001; 211: 1–9.PubMedCrossRef Coffield AB, Maciosek Mv, McGinnis JM, et al. Priorities among recommended clinical preventive services. Am J Prev Med. 2001; 211: 1–9.PubMedCrossRef
11.
go back to reference Fiscella K, Franks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians’ smoking cessation counseling. JAMA. 1996; 27516: 1247–1251.PubMedCrossRef Fiscella K, Franks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians’ smoking cessation counseling. JAMA. 1996; 27516: 1247–1251.PubMedCrossRef
12.
go back to reference Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 2003. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 2003.
13.
go back to reference Hurley SF, Matthews JP. The Quit Benefits Model: A Markov model for assessing the health benefits and health care cost savings of quitting smoking. Cost Eff Resour Allocation. 2007; 235: 2.CrossRef Hurley SF, Matthews JP. The Quit Benefits Model: A Markov model for assessing the health benefits and health care cost savings of quitting smoking. Cost Eff Resour Allocation. 2007; 235: 2.CrossRef
14.
go back to reference Cornuz J, Gilbert A, Pinget C, et al. Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: A multinational comparison. Tob Cont. 2006; 153: 152–159.CrossRef Cornuz J, Gilbert A, Pinget C, et al. Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: A multinational comparison. Tob Cont. 2006; 153: 152–159.CrossRef
15.
go back to reference Tomson T, Helgason AR, Gilljam H. Quitline in smoking cessation: A cost-effectiveness analysis. Int J Technol Assess Health Care. 2004; 204: 469–474.PubMedCrossRef Tomson T, Helgason AR, Gilljam H. Quitline in smoking cessation: A cost-effectiveness analysis. Int J Technol Assess Health Care. 2004; 204: 469–474.PubMedCrossRef
16.
go back to reference Lennox AS, Osman LM, Reiter E, et al. Cost effectiveness of computer tailored and non-tailored smoking letters in general practice: Randomised controlled trial. BMJ. 2001; 3227299: 1396.PubMedCrossRef Lennox AS, Osman LM, Reiter E, et al. Cost effectiveness of computer tailored and non-tailored smoking letters in general practice: Randomised controlled trial. BMJ. 2001; 3227299: 1396.PubMedCrossRef
17.
go back to reference Buck DJ, Richmond RL, Mendelsohn CP. Cost-effectiveness analysis of a family physician delivered smoking cessation program. Prev Med. 2000; 316: 641–648.PubMedCrossRef Buck DJ, Richmond RL, Mendelsohn CP. Cost-effectiveness analysis of a family physician delivered smoking cessation program. Prev Med. 2000; 316: 641–648.PubMedCrossRef
18.
go back to reference Glasgow RE, Klesges LM, Dzewaltowski DA, et al. The future of health behavior change research: What is needed to improve translation of research into health promotion practice? Ann Behav Med. 2004; 271: 3–12. PMID 14979358.PubMedCrossRef Glasgow RE, Klesges LM, Dzewaltowski DA, et al. The future of health behavior change research: What is needed to improve translation of research into health promotion practice? Ann Behav Med. 2004; 271: 3–12. PMID 14979358.PubMedCrossRef
20.
go back to reference Kaplan RM, Groessl EJ. Applications of cost-effectiveness methodologies in behavioral medicine. J Consult Clin Psychol. 2002; 703: 482–493.PubMedCrossRef Kaplan RM, Groessl EJ. Applications of cost-effectiveness methodologies in behavioral medicine. J Consult Clin Psychol. 2002; 703: 482–493.PubMedCrossRef
22.
go back to reference The Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 diabetes mellitus in the Diabetes Prevention Program. Diabetes Care. 2003; 26: 36–47.CrossRef The Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 diabetes mellitus in the Diabetes Prevention Program. Diabetes Care. 2003; 26: 36–47.CrossRef
23.
go back to reference Meenan RT, Stevens VJ, Hornbrook MC, et al. Cost-effectiveness of a hospital-based smoking-cessation intervention. Med Care. 1998; 365: 670–678.PubMedCrossRef Meenan RT, Stevens VJ, Hornbrook MC, et al. Cost-effectiveness of a hospital-based smoking-cessation intervention. Med Care. 1998; 365: 670–678.PubMedCrossRef
24.
go back to reference Ritzwoller DP, Toobert D, Sukhanova A, Glasgow RE. Economic analysis of the Mediterranean Lifestyle Program for Postmenopausal women with diabetes. Diabetes Educ. 2006; 325: 761–769. PMID 16971709.PubMedCrossRef Ritzwoller DP, Toobert D, Sukhanova A, Glasgow RE. Economic analysis of the Mediterranean Lifestyle Program for Postmenopausal women with diabetes. Diabetes Educ. 2006; 325: 761–769. PMID 16971709.PubMedCrossRef
25.
go back to reference Koriat A. How do we know that we know? The accessibility model of the feelling of knowing. Psychol Rev. 1993; 1004: 609–639.PubMedCrossRef Koriat A. How do we know that we know? The accessibility model of the feelling of knowing. Psychol Rev. 1993; 1004: 609–639.PubMedCrossRef
26.
go back to reference Newport DJ, Brennan PA, Green P, et al. Maternal depression and medication exposure during pregnancy: Comparison of maternal recall to prospective documentation. Psychol Rev. 1993; 1004: 609–639.CrossRef Newport DJ, Brennan PA, Green P, et al. Maternal depression and medication exposure during pregnancy: Comparison of maternal recall to prospective documentation. Psychol Rev. 1993; 1004: 609–639.CrossRef
27.
go back to reference Bradburn N, Rips L, Shevell S. Answering autobiographic questions: The impacto memory and inference on surveys. Science, New Series. 1987; 2364798: 157–161. Bradburn N, Rips L, Shevell S. Answering autobiographic questions: The impacto memory and inference on surveys. Science, New Series. 1987; 2364798: 157–161.
28.
go back to reference Levinson AH, Glasgow RE, Gaglio B, et al. Tailored behavioral support for smoking reduction: Development and pilot results of an innovative intervention. Health Educ Res. 2008; 232: 335–346. Apr.PubMedCrossRef Levinson AH, Glasgow RE, Gaglio B, et al. Tailored behavioral support for smoking reduction: Development and pilot results of an innovative intervention. Health Educ Res. 2008; 232: 335–346. Apr.PubMedCrossRef
29.
go back to reference Shiffman S, Gitchell JG, Warner KE, et al. Tobacco harm reduction: conceptual structure and nomenclature for analysis and research. Nicotine Tob Res. 2002; 4Suppl 2: S113–S129.PubMedCrossRef Shiffman S, Gitchell JG, Warner KE, et al. Tobacco harm reduction: conceptual structure and nomenclature for analysis and research. Nicotine Tob Res. 2002; 4Suppl 2: S113–S129.PubMedCrossRef
30.
go back to reference Tunis SR, Stryer DB, Clancey CM. Practical clinical trials. Increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003; 290: 1624–1632.PubMedCrossRef Tunis SR, Stryer DB, Clancey CM. Practical clinical trials. Increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003; 290: 1624–1632.PubMedCrossRef
31.
go back to reference Glasgow RE, Magid DJ, Beck A, et al. Practical clinical trials for translating research to practice: Design and measurement recommendations. Med Care. 2005; 436: 551–557. PMID 15908849.PubMedCrossRef Glasgow RE, Magid DJ, Beck A, et al. Practical clinical trials for translating research to practice: Design and measurement recommendations. Med Care. 2005; 436: 551–557. PMID 15908849.PubMedCrossRef
32.
go back to reference Glasgow RE, Fisher L, Skaff M, et al. Problem-solving and diabetes self-management: Investigation in a large, multi-racial sample. Diabetes Care. 2007; 301: 33–37.PubMedCrossRef Glasgow RE, Fisher L, Skaff M, et al. Problem-solving and diabetes self-management: Investigation in a large, multi-racial sample. Diabetes Care. 2007; 301: 33–37.PubMedCrossRef
34.
go back to reference Keller PA, Bailey LA, Koss KJ, et al. Organization, financing, promotion, and cost of U.S. Quitlines, 2004. Am J Prev Med. 2007; 321: 32–37.PubMedCrossRef Keller PA, Bailey LA, Koss KJ, et al. Organization, financing, promotion, and cost of U.S. Quitlines, 2004. Am J Prev Med. 2007; 321: 32–37.PubMedCrossRef
35.
go back to reference Fishman PA, Thompson E, Merikle E, Curry SJ. Changes in health care costs before and after smoking cessation. Nicotine Tob Res. 2006; 83: 393–401.PubMedCrossRef Fishman PA, Thompson E, Merikle E, Curry SJ. Changes in health care costs before and after smoking cessation. Nicotine Tob Res. 2006; 83: 393–401.PubMedCrossRef
36.
go back to reference Fishman PA, Khan ZM, Thompson EE, Curry SJ. Health care costs among smokers, former smokers, and never smokers in an HMO. Health Serv Res. 2003; 382: 733–749.PubMedCrossRef Fishman PA, Khan ZM, Thompson EE, Curry SJ. Health care costs among smokers, former smokers, and never smokers in an HMO. Health Serv Res. 2003; 382: 733–749.PubMedCrossRef
37.
go back to reference Cutler TW, Palmieri J, Khalsa M, Stebbins M. Evaluation of the relationship between a chronic disease care management program and California pay-for-performance diabetes care cholesterol measures in one medical group. J Manage Care Pharm. 2007; 137: 578–588. Cutler TW, Palmieri J, Khalsa M, Stebbins M. Evaluation of the relationship between a chronic disease care management program and California pay-for-performance diabetes care cholesterol measures in one medical group. J Manage Care Pharm. 2007; 137: 578–588.
Metadata
Title
Costing Behavioral Interventions: A Practical Guide to Enhance Translation
Authors
Debra P. Ritzwoller, Ph.D.
Anna Sukhanova, M.A.
Bridget Gaglio, M.P.H.
Russell E. Glasgow, Ph.D.
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
Annals of Behavioral Medicine / Issue 2/2009
Print ISSN: 0883-6612
Electronic ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-009-9088-5

Other articles of this Issue 2/2009

Annals of Behavioral Medicine 2/2009 Go to the issue